AI-generated summary
This review describes the mechanisms, light sources, dosimetry principles and clinical uses of low-level laser therapy, also called photobiomodulation. The authors summarize conditions that have been studied in randomized controlled trials and suggest that serious conditions such as stroke and spinal cord injury may soon be amenable to this therapy. The abstract does not report pooled findings or certainty of evidence.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract is a narrative review overview and does not report the number of studies, their quality, or the strength of the evidence for any condition.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Biphasic dose response, Traumatic brain injury, Photobiomodulation, Wound healing, Brain injury, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.